BHIC · BioScience Health Innovations, Inc.
$5.00
+0.51 (+11.36%)
At close · Aug 14
Market Cap
$52.77M
Shares
11.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel Schmidt | director | Appointed | 2026-04-02 |
| Justin Earl | Board of Directors | Resigned | 2026-04-02 |
| John Chymboryk | Chief Financial Officer | Appointed | 2023-03-23 |
| Darren López | Chief Executive Officer | Appointed | 2023-03-16 |
| Justin Earl | the sole officer of the Company | Resigned | 2023-03-16 |
| John Chymboryk | Director | Appointed | 2023-03-16 |
| Darren Lopez | Director | Appointed | 2023-03-16 |